Podcast Summary: The Rundown – Buffett Buys Google, Novo Nordisk Cuts Obesity Drug Prices, and Public Launches AI Brokerage

Host: Zaid Admani
Date: November 17, 2025
Podcast: The Rundown by Public.com
Episode Theme:
A high-speed, insightful market update preparing investors for a crucial week in stocks—spotlighting significant moves in the pharma industry (Novo Nordisk, Johnson & Johnson), Warren Buffett’s surprising investment in Google, and Public.com’s launch of a cutting-edge AI-powered investing feature.

Overview

Zaid Admani recaps a pivotal week in financial markets, focusing on upcoming earnings, sector rotations, major pharmaceutical developments, Warren Buffett’s Google investment, and innovative AI-driven investment tools from Public.com.

Key Discussion Points & Insights

1. Market Volatility and Sector Rotation (00:54–02:00)

• S&P 500 eked out a 0.1% gain last week; Nasdaq dipped 0.4% and is now 4% below its recent highs.
• Crypto in a bear market:
  • “Bitcoin is down to around $95,000 which is more than 25% from its record highs... Ether is down to around $3,000 which is more than 30% from its all time highs.” (01:19)
• Movement from riskier assets (AI stocks, crypto) to safer sectors (healthcare +5.2%, energy +3.8% for November so far):
  • “We seem to be in the middle of a market rotation where investors are selling their riskier assets… and putting them into sectors like healthcare and energy.” (01:36)
• Preview of pivotal events:
  • Nvidia earnings Wednesday could be a turning point for AI sentiment.
  • Retail giants (Walmart, Target, TJ Maxx) to report—insights into consumer spending.
  • September U.S. jobs data coming Thursday.
  • “This could be a very crucial week for our portfolio.” (02:29)

2. Novo Nordisk Slashes Obesity Drug Prices (03:02–04:44)

• Novo Nordisk cuts cash price of Wegovy/Ozempic from $499 to $349/month.
  • Intro promo: 2 months for $199 for new patients.
  • “Not only does this undercut Eli Lilly’s prices for Zepbound, but it also undercuts the copycat compound version sold through places like Hims and Hers.” (03:34)
• Strategy: Competing directly with generics/compounds, hoping patients try the real thing and continue for results and retention.
• Broader context:
  • Medicare coverage for the drugs starts in March, thanks to a deal with the Trump administration (TrumpRx system).
  • “More and more Americans will likely be on these weight loss drugs in the near future, not just because of the price cuts, but also because Novo Nordisk and Eli Lilly struck a deal... to lower prices.” (04:05)
• Novo’s tough year: Four downward forecasts in 2025; stock down ~60% from highs.

3. Pharma M&A Frenzy: Johnson & Johnson Acquires Halda (04:45–06:11)

• J&J acquires Halda Therapeutics for $3B to boost its cancer treatment pipeline.
  • “With this acquisition, Johnson and Johnson will add Halda’s proprietary platforms… Their lead drug candidate… targets prostate cancer, which is an area JJ already operates in.” (05:10)
• Broader M&A trend:
  • Merck bought flu treatment makers Sidera for $9.2B.
  • Pfizer acquired obesity drugmaker Medcera for $10B after a bidding war with Novo.
  • “The whole industry is scrambling right now to replace their aging blockbuster drugs and beef up their pipeline.” (06:01)
• Notable light moment:
  • “On a side note, I might have to drop a blooper reel for every time I have to rerecord one of these pharmaceutical names.” (06:11)

4. Warren Buffett’s Berkshire Buys Google (06:13–07:13)

• Berkshire Hathaway disclosed a $4B+ stake in Google—now its 10th biggest holding.
  • “The reason this is notable is because Berkshire doesn’t typically invest in many tech companies. Apple is a rare exception.” (06:21)
• Berkshire sold more Apple (down 15%) and rotated funds into Google.
• Warren Buffett is stepping down at year end; likely, the investment was not led by him:
  • “Now that Warren Buffett is stepping down, maybe Berkshire will make even more tech investments.” (06:51)
• Google stock up over 5% following the news.
  • “It’s kind of crazy to me that a Berkshire investment can still move a big stock like Google.” (07:05)

5. Dell Downgraded on Memory Cost Concerns (07:14–07:34)

• Morgan Stanley double-downgraded Dell; price target cut from $144 to $110.
• Memory prices (DRAM/NAND) surged 50% and 300% in six months, pressuring Dell’s margins.
• Dell stock down over 5% on the downgrade.

6. Public.com Launches AI-Powered Investing: Generated Assets (07:35–08:30)

• New feature: “Generated Assets” allows users to create a custom, AI-driven ETF or index based on any idea.
  • “Think of it like your own personalized ETF… you can describe what you want to invest in, and Public’s AI will turn it into a custom asset.” (07:45)
• Examples: self-driving automation, plant-based products, companies with CEOs under 40.
• Custom indices/ETFs available for users immediately.
• Host’s personal excitement:
  • “Not going to lie, I’m going to be trying it out as soon as I finish recording this podcast and see what kind of custom ETFs I can cook up.” (08:19)
• Call to action: Try the feature, vote in today’s Spotify poll, and share feedback.

Notable Quotes

• “Nvidia is the most important stock in the world right now and every one of their earnings reports feels like life or death.” (01:51) – Zaid Admani
• “More and more Americans will likely be on these weight loss drugs in the near future, not just because of the price cuts, but also because Novo Nordisk and Eli Lilly struck a deal… to lower prices.” (04:05)
• "It’s kind of crazy to me that a Berkshire investment can still move a big stock like Google." (07:05)
• “[Generated Assets] is one of the coolest uses of AI that I’ve seen in investing.” (07:37)
• “Public.com is cooking up some really, really cool features you don’t see any other brokerage doing.” (08:29)

Timestamps for Key Segments

• Market Update & Sector Rotation: 00:54–02:00
• Crucial Nvidia Earnings Preview: 01:51
• Upcoming Retailer & Jobs Data: 02:20–02:29
• Novo Nordisk price cut & pharma sector context: 03:02–04:44
• J&J Acquires Halda, Pharma M&A: 04:45–06:11
• Buffett/Berkshire buys Google: 06:13–07:13
• Dell double downgrade: 07:14–07:34
• Public.com’s AI-generated assets launch: 07:35–08:30

Episode Tone & Style

Zaid’s delivery is high-energy, conversational, and enthusiastic, with a focus on both the “big moves” and actionable nuggets for investors. There’s a blend of analysis, humor, and personal takes, all wrapped in a fast-paced, jargon-light style.

This summary covers all crucial investment updates from the November 17, 2025 episode of The Rundown, making it easy for listeners to get key market developments and innovations without tuning in live.